Prospective open-label, single-arm, multicenter, safety, tolerability, and pharmacokinetic studies of intravenous levetiracetam in children with epilepsy

Journal of Child Neurology

Volumn 28, Issue 11, 2013, Pages 1423-1429

  Weinstock, Arie ^a   Ruiz, Matilde ^b   Gerard, Danielle ^c   Toublanc, Nathalie ^c   Stockis, Armel ^c   Farooq, Osman ^a   Dilley, Deanne ^c   Karmon, Yuval ^a   Elgie, Mary Jo ^a   Schiemann Delgado, Jimmy ^c  

^a UNIVERSITY AT BUFFALO   (United States)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^c UCB PHARMA   (Belgium)

Author keywords

epilepsy; intravenous; levetiracetam; pharmacokinetics

Indexed keywords

ETIRACETAM;

ADD ON THERAPY; ADOLESCENT; ARTICLE; BLOOD CHEMISTRY; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CHILD; CLINICAL ASSESSMENT; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG MEGADOSE; DRUG SAFETY; DRUG SALIVA LEVEL; DRUG TOLERABILITY; ELECTROCARDIOGRAM; EPILEPSY; FEMALE; FEVER; HEMATOLOGY; HUMAN; INFANT; INFUSION RELATED REACTION; INJECTION SITE PAIN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; TREATMENT OUTCOME; VITAL SIGN; VOMITING; XEROSTOMIA;

EID: 84883540852     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813480241     Document Type: Article

References (17)

1. Baulac M, Brodie MJ, Elger CE, et al. Levetiracetam intravenous infusion as an alternative to oral dosing in patients with partial-onset seizures. Epilepsia. 2007 ; 48: 589-592
2. Ramael S, Daoust A, Otoul C, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 2006 ; 47: 1128-35
3. Ramael S, De Smedt F, Toublanc N, et al. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Clin Ther. 2006 ; 28: 734-744
4. Snoeck E, Jacqmin P, Sargentini-Maier ML, Stockis A. Modeling and simulation of intravenous levetiracetam pharmacokinetic profiles in children to evaluate dose adaptation rules. Epilepsy Res. 2007 ; 76: 140-147
5. Toublanc N, Lovern M, Sargentini-Maier ML, Stockis A. Population pharmacokinetic analysis of levetiracetam in pediatric patients with epilepsy aged 1 month to 16 years. Epilepsia. 2009 ; 50 (suppl 4). 131
6. Rouits E, Burton I, Guenole E, et al. Pharmacokinetics of levetiracetam XR 500 mg tablets. Epilepsy Res. 2009 ; 84: 224-231
7. Fountain N, Conry J, Rodriguez-Leyva I, et al. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Epilepsy Res. 2007 ; 74: 60-69
8. Peters CN, Pohlmann-Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus - experience in 102 adult patients. Seizure. 2005 ; 14: 164-169
9. Ramantani G, Ikonomidou C, Walter B, et al. Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol. 2011 ; 15: 1-7
10. Lee YJ, Kang HC, Kim HD, Lee JS. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy. Pediatr Neurol. 2010 ; 42: 86-92
11. Li S, Cao J, Xiao N, Cai F. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy. J Child Neurol. 2010 ; 25: 609-613
12. Obeid M, Pong AW. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy. Epilepsy Res. 2010 ; 91: 101-105
13. Lo BW, Kyu HH, Jichici D, et al. Meta-analysis of randomized trials on first line and adjunctive levetiracetam. Can J Neurol Sci. 2011 ; 38: 475-486
14. Abend NS, Monk HM, Licht DJ, Dlugos DJ. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures. Pediatr Crit Care Med. 2009 ; 10: 505-510
15. Goraya JS, Khurana DS, Valancia I, et al. Intravenous levetiracetam in children with epilepsy. Pediatr Neurol. 2008 ; 38: 177-180
16. Ng YT, Hastriter EV, Cardenas JF, et al. Intravenous levetiracetam in children with seizures: a prospective safety study. J Child Neurol. 2010 ; 25: 551-555
17. Wheless JW, Clarke D, Hovinga CA, et al. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study. J Child Neurol. 2009 ; 24: 946-951